Clinical Trial Update: Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fluorouracil, hydroxyurea, cetuximab with twice-daily intensity-modulated radiation therapy for advanced head and neck cancers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Laryngeal Cancer
• Nasal Cavity Cancer
• Oral Cavity Cancer
• Paranasal Sinus Cancer
• Pharyngeal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FLUOROURACIL (Fluorouracil)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Johnny Kao | Conditions: Head and Neck Cancer, Cancer of the Pharynx | Phase 2 | Status: COMPLETED | Results posted: 2018-03-13